Clicky

IBEX Technologies Inc.(IBT)

Description: IBEX Technologies Inc., through its subsidiaries, IBEX Pharmaceuticals Inc. and BioResearch Products Inc., manufactures and markets enzymes for biomedical use. The Company also manufactures and markets a series of arthritis assays, which enable the study of both the synthesis and degradation of cartilage components. It operates through the production and sale of diagnostic products segment. Its products include IB-C2C-HUSA, C2C Assay, CPII Assay, C1-2C Assay and CS-846 Assay. It provides various individual collagen associated antibodies, such as Ab1320-Rabbit Polyclonal Antibody; Type IX Collagen Antibody, and C1-2C Antibody (Col 2 3/4C short Antibody). Its diagnostic microtiter enzyme-linked immunosorbent assays include C2C-Collagen Type II Cleavage Assay; IB-C2C-HUSA-IBEX C2C Human Urine Sandwich Assay; C1,2C-Collagen Type I and II Cleavage Assay (Col 2 3/4C short antibody); CPII-Procollagen Type II C-Propeptide Assay, and CS846-Aggrecan Chondroitin Sulfate 846 Epitope Assay.


Keywords: Pharmaceutical Biology Immunology Antibodies Antibody Arthritis Pharma Diagnostic Products Enzymes Laboratory Techniques Collagen Assay Peptide Elisa Cartilage

Home Page: www.ibex.ca

IBT Technical Analysis

5485 Rue Pare
Montreal, QC H4P 1P7
Canada
Phone: 514 344 4004


Officers

Name Title
Mr. Paul Baehr Pres, CEO & Chairman
Belinda Franco C.A., CPA CFO, VP of Fin. & Admin. and Sec.
Mahendra Kumar Pallapothu VP of Operations

Exchange: V

Country: CA

Currency: Canadian Dollar (C$)

Forward PE: 0
Trailing PE: 13.1667
Price-to-Book MRQ: 1.2205
Price-to-Sales TTM: 1.5701
IPO Date:
Fiscal Year End: July
Full Time Employees: 0
Back to stocks